ZA941963B - Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation - Google Patents

Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation

Info

Publication number
ZA941963B
ZA941963B ZA941963A ZA941963A ZA941963B ZA 941963 B ZA941963 B ZA 941963B ZA 941963 A ZA941963 A ZA 941963A ZA 941963 A ZA941963 A ZA 941963A ZA 941963 B ZA941963 B ZA 941963B
Authority
ZA
South Africa
Prior art keywords
hydrogen
arylalkoxybenzyl
substituted
preparation
trifluoromethyl
Prior art date
Application number
ZA941963A
Other languages
English (en)
Inventor
Mario Varasi
Philippe Dostert
Paolo Pevarello
Alberto Bonsignori
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA941963B publication Critical patent/ZA941963B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA941963A 1993-04-01 1994-04-21 Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation ZA941963B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939306886A GB9306886D0 (en) 1993-04-01 1993-04-01 Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
ZA941963B true ZA941963B (en) 1994-10-19

Family

ID=10733215

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941963A ZA941963B (en) 1993-04-01 1994-04-21 Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation

Country Status (19)

Country Link
US (1) US5446066A (de)
EP (1) EP0643688B1 (de)
JP (1) JP3542599B2 (de)
KR (1) KR950701904A (de)
CN (1) CN1035938C (de)
AT (1) ATE168991T1 (de)
AU (1) AU667164B2 (de)
CA (1) CA2135783C (de)
DE (1) DE69412016T2 (de)
ES (1) ES2122253T3 (de)
FI (1) FI945581A0 (de)
GB (1) GB9306886D0 (de)
HU (1) HUT68256A (de)
IL (1) IL108969A (de)
NZ (1) NZ262907A (de)
PL (1) PL306537A1 (de)
RU (1) RU94046141A (de)
WO (1) WO1994022808A1 (de)
ZA (1) ZA941963B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
FR2753967B1 (fr) * 1996-09-27 1998-11-27 Sod Conseils Rech Applic Nouveaux derives de la phenoxyethylamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
GB9706730D0 (en) * 1997-04-03 1997-05-21 Pharmacia & Upjohn Spa 2-[(3-substituted)-5-Isoxazolymethylaminojalkanamid derivatives
ES2352739T3 (es) 1997-11-21 2011-02-22 Purdue Neuroscience Company 2-aminoacetamidas sustituidas y el uso de las mismas.
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
WO2000061188A1 (en) * 1999-04-09 2000-10-19 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
SI1423168T1 (sl) 2001-09-03 2006-06-30 Newron Pharm Spa Farmacevtski sestavek, ki vsebuje gabapentin ali njegov analog in alfa-aminoamid, in njegova analgetska uporaba
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
EP1438956A1 (de) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-Aminoamidderivate die als Antimigränemittel nützlich sind
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
EP1524265A1 (de) * 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Prolinamide-Derivate als Natrium- und/oder Kalziumkanalblocker oder selektive MAO-B Inhibitoren
ATE411027T1 (de) * 2003-10-23 2008-10-15 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
EP1588704A1 (de) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamidderivate zur Behandlung des Restless-Leg-Syndroms und der Suchterkrankungen
US20080096965A1 (en) * 2004-09-10 2008-04-24 Newron Pharmaceuticals S.P.A. (Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators
EP1870097A1 (de) 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamidederivate zur Behandlung von kognitiven Störungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) * 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation

Also Published As

Publication number Publication date
GB9306886D0 (en) 1993-05-26
HUT68256A (en) 1995-06-28
JPH07507814A (ja) 1995-08-31
ES2122253T3 (es) 1998-12-16
AU667164B2 (en) 1996-03-07
KR950701904A (ko) 1995-05-17
RU94046141A (ru) 1996-09-27
CN1035938C (zh) 1997-09-24
IL108969A0 (en) 1994-06-24
IL108969A (en) 1998-10-30
JP3542599B2 (ja) 2004-07-14
AU6284294A (en) 1994-10-24
EP0643688B1 (de) 1998-07-29
FI945581A7 (fi) 1994-11-28
CN1104017A (zh) 1995-06-21
FI945581L (fi) 1994-11-28
FI945581A0 (fi) 1994-11-28
DE69412016D1 (de) 1998-09-03
WO1994022808A1 (en) 1994-10-13
US5446066A (en) 1995-08-29
NZ262907A (en) 1996-02-27
PL306537A1 (en) 1995-04-03
CA2135783A1 (en) 1994-10-13
EP0643688A1 (de) 1995-03-22
CA2135783C (en) 2005-06-07
ATE168991T1 (de) 1998-08-15
DE69412016T2 (de) 1999-02-11

Similar Documents

Publication Publication Date Title
GB9306886D0 (en) Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
IL126339A (en) Taxol derivatives
AU3345595A (en) 3-benzoyl benzofuran derivatives as thyroid hormone antagonists
PL295030A1 (en) Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine
DK202882A (da) Fremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater
DE69032020D1 (de) N-Substituierte 4-Pyrimidinamine und -Pyrimidindiamine, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
GB9306899D0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
DE69330601D1 (de) Serotoninergische ergolin derivate
DE3362328D1 (en) (1-arylcyclobutyl) (heterocyclyl) methylamine compounds, their preparation and their use as therapeutic agents
ES2000524A6 (es) Procedimiento para la preparacion de nuevas benzamidas y benzoatos sustituidos.
HU9503852D0 (en) Use of cephem derivatives as anti-metastatic agents
GR3024747T3 (en) 3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers
ES2056025A1 (es) Nuevos derivados de indol.
LTIP1450A (en) Azaspiroalkane derivatives,processes for their preparation and pharmaceutical compositions containing them